NASDAQ:TVTYTivity Health Stock Price, Forecast & News

Tivity Health's stock was trading at $7.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TVTY stock has increased by 40.5% and is now trading at $11.10. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tivity Health.

Tivity Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Tivity Health.

Tivity Health Inc (NASDAQ:TVTY) issued its earnings results on Wednesday, May, 6th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.18) by $0.06. The company earned $337.66 million during the quarter, compared to analyst estimates of $339.52 million. Tivity Health had a negative net margin of 38.98% and a positive return on equity of 20.51%. View Tivity Health's earnings history.

11 brokerages have issued 12-month price targets for Tivity Health's shares. Their forecasts range from $4.00 to $32.00. On average, they expect Tivity Health's share price to reach $17.00 in the next twelve months. This suggests a possible upside of 53.2% from the stock's current price. View analysts' price targets for Tivity Health.

Headlines about TVTY stock have trended very positive on Tuesday, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tivity Health earned a daily sentiment score of 3.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutTivity Health.

Tivity Health saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 13,790,000 shares, an increase of 6.2% from the April 15th total of 12,980,000 shares. Based on an average trading volume of 2,014,500 shares, the short-interest ratio is currently 6.8 days. Approximately 32.8% of the shares of the stock are short sold. View Tivity Health's Current Options Chain.

Some companies that are related to Tivity Health include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include Energy Transfer LP Unit (ET), CBL & Associates Properties (CBL), Canopy Growth (CGC), Netflix (NFLX), Nektar Therapeutics (NKTR), AT&T (T), NVIDIA (NVDA), Applied Materials (AMAT), Cornerstone Total Return Fund (CRF) and salesforce.com (CRM).

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Tivity Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Hudson Executive Capital LP (18.06%), BlackRock Inc. (14.92%), State Street Corp (3.74%), Geode Capital Management LLC (1.37%), Bank of New York Mellon Corp (1.17%) and Assenagon Asset Management S.A. (1.00%). Company insiders that own Tivity Health stock include Bradley S Karro, Donato Tramuto, Ira Sochet, Kevin Wills, Lee Shapiro and Sara Finley. View institutional ownership trends for Tivity Health.

TVTY stock was sold by a variety of institutional investors in the last quarter, including Van Berkom & Associates Inc., Wells Fargo & Company MN, Parametric Portfolio Associates LLC, JPMorgan Chase & Co., Deutsche Bank AG, Russell Investments Group Ltd., Alliancebernstein L.P., and BlackRock Inc.. View insider buying and selling activity for Tivity Health.

TVTY stock was bought by a variety of institutional investors in the last quarter, including Hudson Executive Capital LP, Assenagon Asset Management S.A., Two Sigma Advisers LP, State Street Corp, Voce Capital Management LLC, Thoroughbred Financial Services LLC, Two Sigma Investments LP, and Geode Capital Management LLC. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro, Ira Sochet, Kevin Wills, Lee Shapiro, and Sara Finley. View insider buying and selling activity for Tivity Health.

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TVTY stock can currently be purchased for approximately $11.10.

Tivity Health has a market capitalization of $538.19 million and generates $1.13 billion in revenue each year. The company earns $-286,820,000.00 in net income (profit) each year or $2.02 on an earnings per share basis. Tivity Health employs 500 workers across the globe.

The official website for Tivity Health is www.tivityhealth.com.

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]